Targeting metalloenzymes for therapeutic intervention

AY Chen, RN Adamek, BL Dick, CV Credille… - Chemical …, 2018 - ACS Publications
Metalloenzymes are central to a wide range of essential biological activities, including
nucleic acid modification, protein degradation, and many others. The role of metalloenzymes …

Mechanistic aspects of carotenoid biosynthesis

AR Moise, S Al-Babili, ET Wurtzel - Chemical reviews, 2014 - ACS Publications
Carotenoids represent a large class of terpenoids characterized by an extensively
conjugated polyene chain. The conjugation system imparts carotenoids with excellent light …

Remarkable potential of the α-aminophosphonate/phosphinate structural motif in medicinal chemistry

A Mucha, P Kafarski, Ł Berlicki - Journal of Medicinal Chemistry, 2011 - ACS Publications
R-Aminophosphonic acids are broadly defined as analogues of amino acids in which the
carboxylic group is replaced by a phosphonic acid or related group (usually phosphonous or …

[HTML][HTML] The non-mevalonate pathway of isoprenoid precursor biosynthesis

WN Hunter - Journal of Biological Chemistry, 2007 - ASBMB
The recently discovered non-mevalonate biosynthetic route to isoprenoid precursors is an
essential metabolic pathway in plants, apicomplexan parasites, and many species of …

Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development

M Schlitzer - ChemMedChem: Chemistry Enabling Drug …, 2007 - Wiley Online Library
Since ancient times, humankind has had to struggle against the persistent onslaught of
pathogenic microorganisms. Nowadays, malaria is still the most important infectious disease …

The crystal structure of E. coli 1-deoxy-D-xylulose-5-phosphate reductoisomerase in a ternary complex with the antimalarial compound fosmidomycin and NADPH …

A Mac Sweeney, R Lange, RPM Fernandes… - Journal of molecular …, 2005 - Elsevier
The key enzyme in the non-mevalonate pathway of isoprenoid biosynthesis, 1-deoxy-d-
xylulose 5-phosphate reductoisomerase (DXR) has been shown to be the target enzyme of …

[HTML][HTML] Over 40 years of fosmidomycin drug research: a comprehensive review and future opportunities

T Knak, MA Abdullaziz, S Höfmann, LA Alves Avelar… - Pharmaceuticals, 2022 - mdpi.com
To address the continued rise of multi-drug-resistant microorganisms, the development of
novel drugs with new modes of action is urgently required. While humans biosynthesize the …

Targeting the formation of the cell wall core of M. tuberculosis

CE Barry, DC Crick, MR McNeil - Infectious Disorders-Drug …, 2007 - ingentaconnect.com
Mycobacteria have a unique cell wall, which is rich in drug targets. The cell wall core
consists of a peptidoglycan layer, a mycolic acid layer, and an arabinogalactan …

Targeting the methyl erythritol phosphate (MEP) pathway for novel antimalarial, antibacterial and herbicidal drug discovery: inhibition of 1-deoxy-D-xylulose-5 …

N Singh, G Cheve, MA Avery… - Current pharmaceutical …, 2007 - ingentaconnect.com
The 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway for isoprenoid biosynthesis has
come under increased scrutiny as a target for novel antimalarial, antibacterial and herbicidal …

[HTML][HTML] Structures of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate reductoisomerase provide new insights into catalysis

LM Henriksson, T Unge, J Carlsson, J Åqvist… - Journal of Biological …, 2007 - ASBMB
Isopentenyl diphosphate is the precursor of various isoprenoids that are essential to all
living organisms. It is produced by the mevalonate pathway in humans but by an alternate …